[article]
| Titre : |
A double-blind randomized controlled trial of personalized upper-alpha neurofeedback in children with ADHD |
| Type de document : |
texte imprimé |
| Auteurs : |
Yuliang WANG, Auteur ; Ka Yi HUI, Auteur ; Siu Fung LU, Auteur ; Qing Chuan Hannah LUI, Auteur ; Lawrence MA, Auteur ; Suhail THEPARAMBIL ASHARAF, Auteur ; Davis LAK, Auteur ; David COGHILL, Auteur ; Patrick IP, Auteur ; Tatia Mei Chun LEE, Auteur ; Winnie Wan Yee TSO, Auteur |
| Article en page(s) : |
p.1953-1964 |
| Langues : |
Anglais (eng) |
| Mots-clés : |
ADHD neurofeedback alpha oscillation randomized controlled trial |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Background Neurofeedback (NF) is a nonpharmacological approach for ADHD, but standard protocols often overlook individual EEG variability, potentially limiting efficacy. We report the first double-blind randomized controlled trial of a session-adaptive individualized upper-alpha NF protocol in children with ADHD, based on individualized 1/f?+?alpha model. Methods Forty-eight children (6?12?years) diagnosed with ADHD were randomized to individualized upper-alpha NF (n?=?26) or sham feedback (n?=?22). Participants completed eight 1-h sessions over four weeks. The primary outcome was parent-rated ADHD symptoms on the SWAN scale, measured at baseline, post-treatment, and follow-up. Secondary outcomes included PedsQL, CBCL, SDQ, and neuropsychological tests. Intention-to-treat linear mixed-effects models assessed Time ? Condition interactions; within-group changes were evaluated via paired t-tests. EEG learning was defined as the change in each session's upper-alpha/theta-to-lower-alpha ratio. Results Blinding was preserved (Bang's Index: caregivers?=?0.13; staff?=?0.21). In the NF group, 21/26 children (80.7%) achieved ?learner? status versus 36.4% in sham. Both groups showed significant reductions in ADHD symptoms post-treatment (SWAN Total: NF, d?=??0.879, p?.001; sham, d?=??1.261, p?.001), with no between-group difference (d?=??0.062, p?=?.881). At six months, NF maintained improvements in ADHD symptoms (SWAN Total: d?=??0.713, p?=?.006), without superiority over sham (d?=?0.221, p?=?.633). Neuropsychological testing revealed NF-specific gains in Purdue Pegboard non-preferred hand (d?=?1.093, FDR q?=?.042) and faster CPT-3 reaction time (d?=??1.210, FDR q?=?.025). Conclusions Personalized upper-alpha NF produced higher EEG learning and selective motor-speed improvements but did not outperform sham in reducing parent-rated ADHD symptoms. Eight sessions sufficed for robust EEG modulation, yet non-specific training effects likely drove clinical gains, indicating NF alone may not be an adequate ADHD treatment. |
| En ligne : |
https://doi.org/10.1111/jcpp.70188 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=597 |
in Journal of Child Psychology and Psychiatry > 67-12 (December 2026) . - p.1953-1964
[article] A double-blind randomized controlled trial of personalized upper-alpha neurofeedback in children with ADHD [texte imprimé] / Yuliang WANG, Auteur ; Ka Yi HUI, Auteur ; Siu Fung LU, Auteur ; Qing Chuan Hannah LUI, Auteur ; Lawrence MA, Auteur ; Suhail THEPARAMBIL ASHARAF, Auteur ; Davis LAK, Auteur ; David COGHILL, Auteur ; Patrick IP, Auteur ; Tatia Mei Chun LEE, Auteur ; Winnie Wan Yee TSO, Auteur . - p.1953-1964. Langues : Anglais ( eng) in Journal of Child Psychology and Psychiatry > 67-12 (December 2026) . - p.1953-1964
| Mots-clés : |
ADHD neurofeedback alpha oscillation randomized controlled trial |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Background Neurofeedback (NF) is a nonpharmacological approach for ADHD, but standard protocols often overlook individual EEG variability, potentially limiting efficacy. We report the first double-blind randomized controlled trial of a session-adaptive individualized upper-alpha NF protocol in children with ADHD, based on individualized 1/f?+?alpha model. Methods Forty-eight children (6?12?years) diagnosed with ADHD were randomized to individualized upper-alpha NF (n?=?26) or sham feedback (n?=?22). Participants completed eight 1-h sessions over four weeks. The primary outcome was parent-rated ADHD symptoms on the SWAN scale, measured at baseline, post-treatment, and follow-up. Secondary outcomes included PedsQL, CBCL, SDQ, and neuropsychological tests. Intention-to-treat linear mixed-effects models assessed Time ? Condition interactions; within-group changes were evaluated via paired t-tests. EEG learning was defined as the change in each session's upper-alpha/theta-to-lower-alpha ratio. Results Blinding was preserved (Bang's Index: caregivers?=?0.13; staff?=?0.21). In the NF group, 21/26 children (80.7%) achieved ?learner? status versus 36.4% in sham. Both groups showed significant reductions in ADHD symptoms post-treatment (SWAN Total: NF, d?=??0.879, p?.001; sham, d?=??1.261, p?.001), with no between-group difference (d?=??0.062, p?=?.881). At six months, NF maintained improvements in ADHD symptoms (SWAN Total: d?=??0.713, p?=?.006), without superiority over sham (d?=?0.221, p?=?.633). Neuropsychological testing revealed NF-specific gains in Purdue Pegboard non-preferred hand (d?=?1.093, FDR q?=?.042) and faster CPT-3 reaction time (d?=??1.210, FDR q?=?.025). Conclusions Personalized upper-alpha NF produced higher EEG learning and selective motor-speed improvements but did not outperform sham in reducing parent-rated ADHD symptoms. Eight sessions sufficed for robust EEG modulation, yet non-specific training effects likely drove clinical gains, indicating NF alone may not be an adequate ADHD treatment. |
| En ligne : |
https://doi.org/10.1111/jcpp.70188 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=597 |
|  |